{{DISPLAYTITLE:Indium (<sup>111</sup>In) biciromab}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458273546
| drug_name = Indium (<sup>111</sup>In) biciromab
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = Fab'
| source = o
| target = [[Fibrin]] II, beta chain
<!-- Clinical data -->
| tradename = FibriScint
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category = N/A
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status = Withdrawn
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 138783-13-8
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03111
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Indium (<sup>111</sup>In) biciromab''' ([[International Nonproprietary Name|INN]], trade name '''FibriScint''', developed by [[Centocor]]) was a [[pharmaceutical drug|drug]] targeting [[fibrin]], a protein involved in the clotting of blood.<ref>{{cite journal|last=King|first=David J.|author2=John R. Adair|year=1999|title=Recombinant antibodies for the diagnosis and therapy of human disease|journal=Current Opinion in Drug Discovery & Development|volume=2|issue=2|page=112|issn=1367-6733}}</ref> It was the [[Fab' fragment]] of a [[mouse]] [[monoclonal antibody]] labelled with the [[radioisotope]] [[indium-111]] for the diagnosis of [[thromboembolism]],<ref>[http://www.answers.com/topic/centocor-inc Answers.com: Centocor Ortho Biotech Products, L.P.]</ref> but was withdrawn during [[clinical trial]]s.<ref>[http://www.diagnosticimaging.com/news/display/article/113619/1236557?verify=0 DiagnosticImaging.com: Centocor withdraws imaging agent applications]</ref>

==References==
{{reflist}}

{{Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems}}

[[Category:Janssen Biotech|Biciromab]]


{{monoclonal-antibody-stub}}